{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:44:10Z","timestamp":1776401050979,"version":"3.51.2"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"D1","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA224370"],"award-info":[{"award-number":["CA224370"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA118100"],"award-info":[{"award-number":["P30 CA118100"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH NCATS Clinical and Translational Science Center for UNM","award":["UL1 TR001449"],"award-info":[{"award-number":["UL1 TR001449"]}]},{"name":"Intramural Research Program, Division of Preclinical Innovation, NIH NCATS"},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["NSF-PREM"],"award-info":[{"award-number":["NSF-PREM"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMR-1827745"],"award-info":[{"award-number":["DMR-1827745"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>DrugCentral is a public resource (http:\/\/drugcentral.org) that serves the scientific community by providing up-to-date drug information, as described in previous papers. The current release includes 109 newly approved (October 2018 through March 2020) active pharmaceutical ingredients in the US, Europe, Japan and other countries; and two molecular entities (e.g. mefuparib) of interest for COVID19. New additions include a set of pharmacokinetic properties for \u223c1000 drugs, and a sex-based separation of side effects, processed from FAERS (FDA Adverse Event Reporting System); as well as a drug repositioning prioritization scheme based on the market availability and intellectual property rights forFDA approved drugs. In the context of the COVID19 pandemic, we also incorporated REDIAL-2020, a machine learning platform that estimates anti-SARS-CoV-2 activities, as well as the \u2018drugs in news\u2019 feature offers a brief enumeration of the most interesting drugs at the present moment. The full database dump and data files are available for download from the DrugCentral web portal.<\/jats:p>","DOI":"10.1093\/nar\/gkaa997","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T19:24:19Z","timestamp":1602703459000},"page":"D1160-D1169","source":"Crossref","is-referenced-by-count":172,"title":["DrugCentral 2021 supports drug discovery and repositioning"],"prefix":"10.1093","volume":"49","author":[{"given":"Sorin","family":"Avram","sequence":"first","affiliation":[{"name":"Department of Computational Chemistry, \u201cCoriolan Dragulescu\u2019\u2019 Institute of Chemistry, 24 Mihai Viteazu Blvd, Timi\u015foara, Timi\u015f, 300223, Rom\u00e2nia"}]},{"given":"Cristian G","family":"Bologa","sequence":"additional","affiliation":[{"name":"Translational Informatics Division, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA"},{"name":"UNM Comprehensive Cancer Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA"}]},{"given":"Jayme","family":"Holmes","sequence":"additional","affiliation":[{"name":"Translational Informatics Division, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA"}]},{"given":"Giovanni","family":"Bocci","sequence":"additional","affiliation":[{"name":"Translational Informatics Division, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA"}]},{"given":"Thomas B","family":"Wilson","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2591-9948","authenticated-orcid":false,"given":"Dac-Trung","family":"Nguyen","sequence":"additional","affiliation":[{"name":"National Center for Advancing Translational Science, 9800 Medical Center Drive, Rockville, MD 20850, USA"}]},{"given":"Ramona","family":"Curpan","sequence":"additional","affiliation":[{"name":"Department of Computational Chemistry, \u201cCoriolan Dragulescu\u2019\u2019 Institute of Chemistry, 24 Mihai Viteazu Blvd, Timi\u015foara, Timi\u015f, 300223, Rom\u00e2nia"}]},{"given":"Liliana","family":"Halip","sequence":"additional","affiliation":[{"name":"Department of Computational Chemistry, \u201cCoriolan Dragulescu\u2019\u2019 Institute of Chemistry, 24 Mihai Viteazu Blvd, Timi\u015foara, Timi\u015f, 300223, Rom\u00e2nia"}]},{"given":"Alina","family":"Bora","sequence":"additional","affiliation":[{"name":"Department of Computational Chemistry, \u201cCoriolan Dragulescu\u2019\u2019 Institute of Chemistry, 24 Mihai Viteazu Blvd, Timi\u015foara, Timi\u015f, 300223, Rom\u00e2nia"}]},{"given":"Jeremy J","family":"Yang","sequence":"additional","affiliation":[{"name":"Translational Informatics Division, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA"}]},{"given":"Jeffrey","family":"Knockel","sequence":"additional","affiliation":[{"name":"Department of Computer Science, University of New Mexico, Albuquerque, NM 87131, USA"}]},{"given":"Suman","family":"Sirimulla","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, School of Pharmacy, The University of Texas at El Paso, TX 79902, USA"}]},{"given":"Oleg","family":"Ursu","sequence":"additional","affiliation":[{"name":"Computational and Structural Chemistry, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6195-6976","authenticated-orcid":false,"given":"Tudor I","family":"Oprea","sequence":"additional","affiliation":[{"name":"Translational Informatics Division, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA"},{"name":"Computational and Structural Chemistry, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA"},{"name":"Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, 40530 Gothenburg, Sweden"},{"name":"Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark"}]}],"member":"286","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"2021010313125881700_B1","doi-asserted-by":"crossref","first-page":"D932","DOI":"10.1093\/nar\/gkw993","article-title":"DrugCentral: online drug compendium","volume":"45","author":"Ursu","year":"2017","journal-title":"Nucleic. Acids. Res."},{"key":"2021010313125881700_B2","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","author":"UniProtConsortium","year":"2019","journal-title":"Nucleic. Acids. Res."},{"key":"2021010313125881700_B3","doi-asserted-by":"crossref","first-page":"D1214","DOI":"10.1093\/nar\/gkv1031","article-title":"ChEBI in 2016: Improved services and an expanding collection of metabolites","volume":"44","author":"Hastings","year":"2016","journal-title":"Nucleic. Acids. Res."},{"key":"2021010313125881700_B4","doi-asserted-by":"crossref","first-page":"e26726","DOI":"10.7554\/eLife.26726","article-title":"Systematic integration of biomedical knowledge prioritizes drugs for repurposing","volume":"6","author":"Himmelstein","year":"2017","journal-title":"Elife"},{"key":"2021010313125881700_B5","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.jmb.2019.02.027","article-title":"GUILDify v2.0: A tool to identify molecular networks underlying human diseases, their comorbidities and their druggable targets","volume":"431","author":"Aguirre-Plans","year":"2019","journal-title":"J. Mol. Biol."},{"key":"2021010313125881700_B6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1758-2946-5-3","article-title":"UniChem: a unified chemical structure cross-referencing and identifier tracking system","volume":"5","author":"Chambers","year":"2013","journal-title":"J. Cheminform."},{"key":"2021010313125881700_B7","first-page":"S1","article-title":"The concise guide to pharmacology 2019\/20: Introduction and other protein targets","volume":"176","author":"Alexander","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"2021010313125881700_B8","doi-asserted-by":"crossref","first-page":"170029","DOI":"10.1038\/sdata.2017.29","article-title":"A standard database for drug repositioning","volume":"4","author":"Brown","year":"2017","journal-title":"Scientific Data"},{"key":"2021010313125881700_B9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1186\/s12859-019-3297-0","article-title":"Time-resolved evaluation of compound repositioning predictions on a text-mined knowledge network","volume":"20","author":"Mayers","year":"2019","journal-title":"BMC Bioinformatics"},{"key":"2021010313125881700_B10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.crtox.2020.06.001","article-title":"Development of an adverse drug event network to predict drug toxicity","volume":"1","author":"Wu","year":"2020","journal-title":"Current Research in Toxicology"},{"key":"2021010313125881700_B11","doi-asserted-by":"crossref","first-page":"D963","DOI":"10.1093\/nar\/gky963","article-title":"DrugCentral 2018: an update","volume":"47","author":"Ursu","year":"2019","journal-title":"Nucleic. Acids. Res."},{"key":"2021010313125881700_B12","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/s41587-020-0686-x","article-title":"Artificial intelligence, drug repurposing and peer review","volume":"38","author":"Levin","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"2021010313125881700_B13","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jcim.0c00826","article-title":"Off-patent drug repositioning","author":"Avram","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"2021010313125881700_B14","article-title":"REDIAL-2020: A suite of machine learning models to estimate Anti-SARS-CoV-2 activities","author":"KC","year":"2020"},{"key":"2021010313125881700_B15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/d41573-020-00052-w","article-title":"Novel drug targets in 2019","volume":"19","author":"Avram","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"2021010313125881700_B16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41573-019-0049-9","article-title":"Therapies for rare diseases: therapeutic modalities, progress and challenges ahead","volume":"19","author":"Tambuyzer","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"2021010313125881700_B17","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: towards direct deposition of bioassay data","volume":"47","author":"Mendez","year":"2019","journal-title":"Nucleic. Acids. Res."},{"key":"2021010313125881700_B18","doi-asserted-by":"crossref","first-page":"D590","DOI":"10.1093\/nar\/gky962","article-title":"New approach for understanding genome variations in KEGG","volume":"47","author":"Kanehisa","year":"2019","journal-title":"Nucleic. Acids. Res."},{"key":"2021010313125881700_B19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrd.2018.14","article-title":"Unexplored therapeutic opportunities in the human genome","volume":"17","author":"Oprea","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"2021010313125881700_B20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets","volume":"16","author":"Santos","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"2021010313125881700_B21","first-page":"328","article-title":"Novel drug targets in 2018","volume":"18","author":"Ursu","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"2021010313125881700_B22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"key":"2021010313125881700_B23","doi-asserted-by":"crossref","first-page":"e65390","DOI":"10.1371\/journal.pone.0065390","article-title":"The SPECIES and ORGANISMS resources for fast and accurate identification of taxonomic names in text","volume":"8","author":"Pafilis","year":"2013","journal-title":"PLoS One"},{"key":"2021010313125881700_B24","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1074\/mcp.M800264-MCP200","article-title":"Antibodypedia, a portal for sharing antibody and antigen validation data","volume":"7","author":"Bj\u00f6rling","year":"2008","journal-title":"Mol. Cell. Proteomics"},{"key":"2021010313125881700_B25","doi-asserted-by":"crossref","first-page":"D995","DOI":"10.1093\/nar\/gkw1072","article-title":"Pharos: Collating protein information to shed light on the druggable genome","volume":"45","author":"Nguyen","year":"2017","journal-title":"Nucleic. Acids. Res."},{"key":"2021010313125881700_B26","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaa993","article-title":"TCRD and Pharos 2021: Mining the human proteome for disease biology","author":"Sheils","year":"2021","journal-title":"Nucleic. Acids. Res."},{"key":"2021010313125881700_B27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1109\/I-SPAN.2009.84","article-title":"Medical terminologies that work: The example of MeSH","volume-title":"2009 10th International Symposium on Pervasive Systems, Algorithms, and Networks","author":"Nelson","year":"2009"},{"key":"2021010313125881700_B28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/adt.2015.29011.tiodrrr","article-title":"Computational and practical aspects of drug repositioning","volume":"13","author":"Oprea","year":"2015","journal-title":"Assay Drug Dev. Technol."},{"key":"2021010313125881700_B29","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s11095-013-1222-1","article-title":"Critical evaluation of human oral bioavailability for pharmaceutical drugs by using various cheminformatics approaches","volume":"31","author":"Kim","year":"2014","journal-title":"Pharm. Res."},{"key":"2021010313125881700_B30","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1124\/dmd.118.082966","article-title":"Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 1352 drug compounds","volume":"46","author":"Lombardo","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"2021010313125881700_B31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1208\/s12248-011-9290-9","article-title":"BDDCS applied to over 900 drugs","volume":"13","author":"Benet","year":"2011","journal-title":"AAPS J."},{"key":"2021010313125881700_B32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1208\/s12248-015-9845-2","article-title":"BDDCS predictions, Self-Correcting aspects of BDDCS assignments, BDDCS assignment corrections, and classification for more than 175 additional drugs","volume":"18","author":"Hosey","year":"2016","journal-title":"AAPS J."},{"key":"2021010313125881700_B33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.yrtph.2004.08.004","article-title":"Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose","volume":"40","author":"Contrera","year":"2004","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"2021010313125881700_B34","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s11095-009-9924-0","article-title":"The role of transporters in the pharmacokinetics of orally administered drugs","volume":"26","author":"Shugarts","year":"2009","journal-title":"Pharm. Res."},{"key":"2021010313125881700_B35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.addr.2011.12.008","article-title":"Improving the prediction of the brain disposition for orally administered drugs using BDDCS","volume":"64","author":"Broccatelli","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2021010313125881700_B36","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.drudis.2019.09.021","article-title":"Can BDDCS illuminate targets in drug design?","volume":"24","author":"Bocci","year":"2019","journal-title":"Drug Discov. Today"},{"key":"2021010313125881700_B37","first-page":"xv","article-title":"In search of the 70-kg man","volume":"102","author":"Ashar","year":"2018","journal-title":"Med. Clin. North Am."},{"key":"2021010313125881700_B38","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1198\/jasa.2011.ap10243","article-title":"A likelihood ratio test based method for signal detection with application to FDA\u2019s drug safety data","volume":"106","author":"Huang","year":"2011","journal-title":"J. Am. Stat. Assoc."},{"key":"2021010313125881700_B39","doi-asserted-by":"crossref","first-page":"24955","DOI":"10.1038\/srep24955","article-title":"Systematic analysis of adverse event reports for sex differences in adverse drug events","volume":"6","author":"Yu","year":"2016","journal-title":"Sci. Rep."},{"key":"2021010313125881700_B40","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/bcp.13923","article-title":"Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: An explorative observational study","volume":"85","author":"de\u00a0Vries","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2021010313125881700_B41","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/465688a","article-title":"Sex bias in trials and treatment must end","volume":"465","author":"Kim","year":"2010","journal-title":"Nature"},{"key":"2021010313125881700_B42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00335-019-09809-0","article-title":"Exploring the dark genome: implications for precision medicine","volume":"30","author":"Oprea","year":"2019","journal-title":"Mamm. Genome"},{"key":"2021010313125881700_B43","doi-asserted-by":"crossref","DOI":"10.1101\/2020.06.04.135046","article-title":"An OpenData portal to share COVID-19 drug repurposing data in real time","author":"Brimacombe","year":"2020"},{"key":"2021010313125881700_B44","doi-asserted-by":"crossref","DOI":"10.1101\/2020.08.18.255877","article-title":"Drug repurposing screen for compounds inhibiting the cytopathic effect of SARS-CoV-2","author":"Chen","year":"2020"},{"key":"2021010313125881700_B45","doi-asserted-by":"crossref","DOI":"10.1101\/2020.06.16.154708","article-title":"Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay","author":"Hanson","year":"2020"},{"key":"2021010313125881700_B46","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1021\/acsptsci.0c00108","article-title":"Identification of SARS-CoV-2 3CL protease inhibitors by a quantitative high-throughput screening","volume":"3","author":"Zhu","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"2021010313125881700_B47","first-page":"2825","article-title":"Scikit-learn: Machine learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J. Mach. Learn Res."},{"key":"2021010313125881700_B48","doi-asserted-by":"crossref","DOI":"10.1016\/j.mjafi.2020.08.004","article-title":"Favipiravir: A new and emerging antiviral option in COVID-19","author":"Agrawal","year":"2020","journal-title":"Armed Forces Med. J. India"}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/49\/D1\/D1160\/35364825\/gkaa997.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/49\/D1\/D1160\/35364825\/gkaa997.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T20:39:42Z","timestamp":1617914382000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article\/49\/D1\/D1160\/5957163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":48,"journal-issue":{"issue":"D1","published-online":{"date-parts":[[2020,11,5]]},"published-print":{"date-parts":[[2021,1,8]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkaa997","relation":{},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1,8]]},"published":{"date-parts":[[2020,11,5]]}}}